warning about possible liver toxicity in patients taking Rezulin (troglitazone)
December 1997
Parke-Davis is warning about possible liver toxicity in patients taking Rezulin (troglitazone).
This could be extremely important. Rezulin is being given to many type 2 diabetics since it came out last January.
But now there are 35 reports of liver damage...resulting in one liver transplant and one death.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote